Company Encyclopedia
View More
name
DOCTOR
300622.SZ
Doctorglasses Chain Co.,Ltd. engages in the retail of eyewear in China. It offers optical glasses; smart glasses; ready-to-wear glasses series, including sunglasses, reading glasses, etc.; contact lenses; soft/hard contact lenses; care solutions, and eye health peripheral products. The company provides eye examinations and fitting, wearing, and debugging, to after-sales visit.
210.26 B
300622.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Other Specialty RetailIndustry
Industry Ranking1/8
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE13.21%B
    • Profit Margin7.89%B
    • Gross Margin53.11%B
  • Growth ScoreB
    • Revenue YoY15.38%B
    • Net Profit YoY-5.25%C
    • Total Assets YoY3.60%C
    • Net Assets YoY7.54%B
  • Cash ScoreB
    • Cash Flow Margin1267.00%B
    • OCF YoY15.38%B
  • Operating ScoreA
    • Turnover1.05A
  • Debt ScoreB
    • Gearing Ratio35.30%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    DOCTOR released its performance for the first three quarters, with a net profit attributable to the parent company of 87.8313 million yuan, an increase of 5.21%

    DOCTOR released its Q3 2025 report, with operating revenue for the first three quarters amounting to 1.08 billion yuan, a year-on-year increase of 18.05%. The net profit attributable to shareholders of the listed company was 87.8313 million yuan, a year-on-year increase of 5.21%. The net profit after deducting non-recurring gains and losses was 78.9989 million yuan, a year-on-year increase of 7.82%. The basic earnings per share were 0.39 yuan

    Zhitong·
    SZ
    300622
    +7.09%
    Zhitong·
    SZ
    300622
    +7.09%

    DOCTOR completed the cancellation of 8,736 stock options, and the capital structure remains unchanged

    DOCTOR Chain Co., Ltd. held a board of directors and supervisory board meeting on August 26, 2025, to decide to cancel 8,736 expired stock options that had not been exercised. These stock options belong to the 2021 Restricted Stock and Stock Option Incentive Plan, with the third exercise period expiring on June 27, 2025. The cancellation has been completed and does not affect the company's capital structure

    Zhitong·
    SZ
    300622
    +7.09%
    Zhitong·
    SZ
    300622
    +7.09%

    White House Floats Doctor Exemptions for $100,000 Visa Fee

    Doctors may be exempt from the Trump administration’s new $100,000 fee for high-skilled H-1B visa applications, the White House said Monday, after some of the biggest medical bodies called out the risk to rural America where there’s already a dearth of providers.

    MSN·
    SZ
    300622
    +7.09%
    MSN·
    SZ
    300622
    +7.09%

    IDC: In the second quarter of 2025, the shipment volume of smart glasses in the Chinese market will reach 664,000 units, a year-on-year increase of 145.5%

    According to the latest report from IDC, the global smart glasses market shipment volume will reach 2.555 million units in the second quarter of 2025, a year-on-year increase of 54.9%. Among them, the shipment volume in the Chinese market is 664,000 units, a year-on-year increase of 145.5%. Audio and audio recording glasses performed exceptionally well in the Chinese market, with a shipment volume of 514,000 units, a year-on-year increase of 256.6%. The AR/VR market shipment volume is 150,000 units, a year-on-year increase of 18.7%. The market competition landscape has changed significantly, with the Thunderbird Air 3S and new products from Xiaomi driving the increase in market share

    Zhitong·
    US
    XIACY
    +2.05%
    HK
    01810
    +1.91%
    SZ
    300622
    +7.09%
    Zhitong·
    US
    XIACY
    +2.05%
    HK
    01810
    +1.91%
    SZ
    300622
    +7.09%

    DOCTOR released its performance for the first half of the year, with a net profit attributable to the parent company of 56.0334 million yuan, an increase of 6.97%

    According to the Zhitong Finance APP, DOCTOR released its semi-annual report for 2025, showing an operating income of 686 million yuan, a year-on-year increase of 14.22%. The net profit attributable to shareholders of the listed company was 56.0334 million yuan, a year-on-year increase of 6.97%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 49.6452 million yuan, a year-on-year increase of 8.24%. The basic earnings per share were 0.25 yuan

    Zhitong·
    SZ
    300622
    +7.09%
    Zhitong·
    SZ
    300622
    +7.09%
    © 2025 Longbridge｜Disclaimer